Bio-X Affiliated Faculty

Dr. Sledge's group is evaluating new means of examining circulating tumor cells in patients with breast cancer with the intent of improving therapy and reducing drug resistance. In separate work, they are studying the use of a "Big Data" approach to breast cancer through the Oncoshare project, which brings together multiple clinical databases.